1.
Alexander-Curtis M, Duan J, Seeklander A, Scott S, Norton N, Wong CL, Salman S, Verdoorn TA. Safety, tolerability and pharmacokinetic profile of recombinant human tissue kallikrein, DM199, after intravenous and subcutaneous administration in healthy volunteers. Int J Clin Trials [Internet]. 2017 Oct. 26 [cited 2025 Dec. 25];4(4):139-46. Available from: https://www.ijclinicaltrials.com/index.php/ijct/article/view/238